• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

绝经后良性甲状腺结节生长缓慢:绝经后女性无需长期甲状腺素抑制治疗。

Slow growth of benign thyroid nodules after menopause: no need for long-term thyroxine suppressive therapy in post-menopausal women.

作者信息

Costante G, Crocetti U, Schifino E, Ludovico O, Capula C, Nicotera M, Arturi F, Filetti S

机构信息

Department of Clinical and Experimental Medicine, University of Catanzaro, Catanzaro, Italy.

出版信息

J Endocrinol Invest. 2004 Jan;27(1):31-6. doi: 10.1007/BF03350907.

DOI:10.1007/BF03350907
PMID:15053240
Abstract

Benign thyroid nodules represent a very common disorder, the management of which is still controversial. The aim of the present work was to evaluate by ultrasound examination the volume changes of thyroid nodules in post-menopausal women presenting single palpable nodular goiter of recent onset (less than 6 months from diagnosis). Forty-three patients received L-T4-treatment, 38 represented the no-treatment group. Long-term follow up (3 and 5 yr) did not show any significant change in the mean volume nodule in these patients. In the no-treatment group, the mean nodule volumes were stable over time from baseline to 5 yr. No significant difference was observed at any follow-up evaluation between thyroid hormone treated and untreated patients. After 1 yr of treatment, a significant decrease (p = 0.0275) in mean nodule volume occurred only for nodules with a baseline volume lower than 1.5 ml. The frequency of clinically relevant nodule size variation showed a more frequent decrease (13.9%) at 1 yr in the L-T4 group, as compared to the no-treatment group (2.6%), while the proportion of increased volume at 1 yr was higher in the untreated than in the L-T4 group (5.3% vs 2.3%). This inverse relationship between the 2 groups was not statistically significant (p = 0.076). In conclusion, an arrest in the growth of benign thyroid nodules occurs in the majority of women after menopause. Only a very limited number of these patients may benefit from thyroid hormone suppressive treatment.

摘要

良性甲状腺结节是一种非常常见的疾病,其治疗方法仍存在争议。本研究的目的是通过超声检查评估绝经后妇女近期出现的单发可触及结节性甲状腺肿(诊断后不到6个月)中甲状腺结节的体积变化。43例患者接受左甲状腺素(L-T4)治疗,38例为未治疗组。长期随访(3年和5年)显示这些患者的平均结节体积没有任何显著变化。在未治疗组中,从基线到5年,平均结节体积随时间保持稳定。在任何随访评估中,甲状腺激素治疗组和未治疗组之间均未观察到显著差异。治疗1年后,仅基线体积小于1.5 ml的结节平均体积出现显著下降(p = 0.0275)。与未治疗组(2.6%)相比,L-T4组在1年时临床相关结节大小变化的频率显示出更频繁的减小(13.9%),而未治疗组1年时体积增加的比例高于L-T4组(5.3%对2.3%)。两组之间的这种反比关系无统计学意义(p = 0.076)。总之,大多数绝经后女性的良性甲状腺结节生长会停止。这些患者中只有极少数可能从甲状腺激素抑制治疗中获益。

相似文献

1
Slow growth of benign thyroid nodules after menopause: no need for long-term thyroxine suppressive therapy in post-menopausal women.绝经后良性甲状腺结节生长缓慢:绝经后女性无需长期甲状腺素抑制治疗。
J Endocrinol Invest. 2004 Jan;27(1):31-6. doi: 10.1007/BF03350907.
2
Levothyroxine suppressive therapy is partially effective in treating patients with benign, solid thyroid nodules and multinodular goiters.左甲状腺素抑制疗法在治疗良性实性甲状腺结节和多结节性甲状腺肿患者方面部分有效。
Thyroid. 1997 Oct;7(5):691-7. doi: 10.1089/thy.1997.7.691.
3
[Efficacy of L-thyroxine (L-T4) therapy on the volume of the thyroid gland and nodules in patients with euthyroid nodular goiter (ENG)].左旋甲状腺素(L-T4)治疗对甲状腺功能正常的结节性甲状腺肿(ENG)患者甲状腺及结节体积的疗效
Minerva Med. 1992 Nov;83(11):745-51.
4
Long-term changes in nodular goiter: a 5-year prospective randomized trial of levothyroxine suppressive therapy for benign cold thyroid nodules.结节性甲状腺肿的长期变化:一项为期5年的左甲状腺素抑制疗法治疗良性冷性甲状腺结节的前瞻性随机试验。
J Clin Endocrinol Metab. 1998 Mar;83(3):780-3. doi: 10.1210/jcem.83.3.4615.
5
Effect of percutaneous ethanol injection therapy versus suppressive doses of L-thyroxine on benign solitary solid cold thyroid nodules: a randomized trial.经皮乙醇注射疗法与抑制剂量的左甲状腺素对良性孤立性实性冷甲状腺结节的影响:一项随机试验。
J Clin Endocrinol Metab. 1998 Mar;83(3):830-5. doi: 10.1210/jcem.83.3.4673.
6
Evolution of benign thyroid nodules under levothyroxine non-suppressive therapy.左甲状腺素非抑制治疗下良性甲状腺结节的演变。
J Endocrinol Invest. 2014 Dec;37(12):1181-6. doi: 10.1007/s40618-014-0128-z. Epub 2014 Jul 10.
7
Long-term follow-up of thyroid nodule growth.甲状腺结节生长的长期随访
Exp Clin Endocrinol Diabetes. 2002 Oct;110(7):348-54. doi: 10.1055/s-2002-34992.
8
Effects on bone mineral density by treatment of benign nodular goiter with mildly suppressive doses of L-thyroxine in a cohort women study.在一项队列女性研究中,用轻度抑制剂量的左甲状腺素治疗良性结节性甲状腺肿对骨矿物质密度的影响。
Horm Res. 2005;64(6):293-8. doi: 10.1159/000089489. Epub 2005 Nov 1.
9
Changes in both size and cytological features of thyroid nodule after levothyroxine treatment.左甲状腺素治疗后甲状腺结节大小及细胞学特征的变化。
Clin Endocrinol (Oxf). 2003 Sep;59(3):347-53. doi: 10.1046/j.1365-2265.2003.01854.x.
10
Levothyroxine suppressive therapy for solitary thyroid nodule.左甲状腺素抑制疗法用于孤立性甲状腺结节
J Endocrinol Invest. 1995 Nov;18(10):796-9. doi: 10.1007/BF03349813.

引用本文的文献

1
Prevalence of thyroid nodule and relationship with physiological and psychosocial factors among adults in Zhejiang Province, China: a baseline survey of a cohort study.中国浙江省成年人甲状腺结节的流行情况及其与生理和心理社会因素的关系:一项队列研究的基线调查。
BMC Public Health. 2024 Jul 11;24(1):1854. doi: 10.1186/s12889-024-19375-z.
2
Effect of Pregnancy and Menopause on Micropapillary Thyroid Carcinomas During Active Surveillance.妊娠和绝经对微小乳头状甲状腺癌主动监测期间的影响。
J Endocr Soc. 2023 Aug 25;7(9):bvad109. doi: 10.1210/jendso/bvad109. eCollection 2023 Aug 2.
3
Glucose Metabolism Derangements and Thyroid Nodules: Does Sex Matter?

本文引用的文献

1
Management of simple nodular goiter: current status and future perspectives.单纯性结节性甲状腺肿的管理:现状与未来展望。
Endocr Rev. 2003 Feb;24(1):102-32. doi: 10.1210/er.2002-0016.
2
Effects of thyroid-stimulating hormone suppression with levothyroxine in reducing the volume of solitary thyroid nodules and improving extranodular nonpalpable changes: a randomized, double-blind, placebo-controlled trial by the French Thyroid Research Group.左甲状腺素抑制促甲状腺激素对缩小甲状腺单发结节体积及改善结节外不可触及变化的影响:法国甲状腺研究小组的一项随机、双盲、安慰剂对照试验
J Clin Endocrinol Metab. 2002 Nov;87(11):4928-34. doi: 10.1210/jc.2002-020365.
3
葡萄糖代谢紊乱与甲状腺结节:性别有影响吗?
J Pers Med. 2022 May 30;12(6):903. doi: 10.3390/jpm12060903.
4
Uterine fibroids increase the risk of thyroid goiter and thyroid nodules.子宫肌瘤增加甲状腺肿和甲状腺结节的风险。
Sci Rep. 2022 Apr 22;12(1):6620. doi: 10.1038/s41598-022-10625-x.
5
Association of Changes in Metabolic Syndrome Status With the Incidence of Thyroid Nodules: A Prospective Study in Chinese Adults.代谢综合征状态变化与甲状腺结节发病的相关性:一项中国成年人的前瞻性研究。
Front Endocrinol (Lausanne). 2020 Aug 21;11:582. doi: 10.3389/fendo.2020.00582. eCollection 2020.
6
The association of menstrual and reproductive factors with thyroid nodules in Chinese women older than 40 years of age.40岁以上中国女性月经和生殖因素与甲状腺结节的关联。
Endocrine. 2015 Mar;48(2):603-14. doi: 10.1007/s12020-014-0342-7. Epub 2014 Jul 11.
7
Natural course of cytologically benign thyroid nodules: observation of ultrasonographic changes.甲状腺良性细胞学结节的自然病程:超声变化观察。
Endocrinol Metab (Seoul). 2013 Jun;28(2):110-8. doi: 10.3803/EnM.2013.28.2.110. Epub 2013 Jun 18.
8
Thyroxine suppression therapy for benign, non-functioning solitary thyroid nodules: a quality-effects meta-analysis.甲状腺素抑制疗法治疗良性、无功能的孤立性甲状腺结节:一项质量效应荟萃分析。
Clin Med Res. 2010 Dec;8(3-4):150-8. doi: 10.3121/cmr.2010.881. Epub 2010 Aug 25.
Effectiveness of thyroid hormone suppressive therapy in benign solitary thyroid nodules: a meta-analysis.
甲状腺激素抑制疗法对良性孤立性甲状腺结节的有效性:一项荟萃分析。
J Clin Endocrinol Metab. 2002 Sep;87(9):4154-9. doi: 10.1210/jc.2001-011762.
4
Iodine deficiency in Calabria: characterization of endemic goiter and analysis of different indicators of iodine status region-wide.
J Endocrinol Invest. 2002 Mar;25(3):201-7. doi: 10.1007/BF03343991.
5
Management of the nontoxic multinodular goitre: a European questionnaire study.非毒性多结节性甲状腺肿的管理:一项欧洲问卷调查研究。
Clin Endocrinol (Oxf). 2000 Jul;53(1):5-12. doi: 10.1046/j.1365-2265.2000.01060.x.
6
Management of the solitary thyroid nodule: results of a North American survey.孤立性甲状腺结节的管理:一项北美调查的结果。
J Clin Endocrinol Metab. 2000 Jul;85(7):2493-8. doi: 10.1210/jcem.85.7.6672.
7
Clinical review 101: Thyrotropin may not be the dominant growth factor in benign and malignant thyroid tumors.临床综述101:促甲状腺素可能并非良恶性甲状腺肿瘤的主要生长因子。
J Clin Endocrinol Metab. 1999 Mar;84(3):829-34. doi: 10.1210/jcem.84.3.5519.
8
The spectrum of thyroid disorders in an iodine-deficient community: the Pescopagano survey.碘缺乏社区的甲状腺疾病谱:佩斯科普加诺调查
J Clin Endocrinol Metab. 1999 Feb;84(2):561-6. doi: 10.1210/jcem.84.2.5508.
9
Suppressive therapy with levothyroxine for solitary thyroid nodules: a double-blind controlled clinical study and cumulative meta-analyses.左甲状腺素对孤立性甲状腺结节的抑制治疗:一项双盲对照临床研究及累积荟萃分析。
J Clin Endocrinol Metab. 1998 Nov;83(11):3881-5. doi: 10.1210/jcem.83.11.5215.
10
Clinical case seminar: Reentrant atrioventricular nodal tachycardia induced by levothyroxine.
J Clin Endocrinol Metab. 1998 Aug;83(8):2643-5. doi: 10.1210/jcem.83.8.5000.